Giulia C. Kennedy, Chief Scientific & Med Officer at VERACYTE, INC. (VCYT), sold 101,124 shares at $52.38 ($5.0M) on 2021-03-04, disclosed to the SEC on 2021-03-08.
Open-market sale of $5.0M VCYT by Chief Scientific & Med Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $47.11 | 20,239 | $953K | 19.2% |
| 2 | $47.11 | 20,239 | $953K | 19.2% |
| 3 | $48.29 | 8,483 | $410K | 8.2% |
| 4 | $48.29 | 8,483 | $410K | 8.2% |
| 5 | $49.22 | 2,991 | $147K | 3.0% |
| 6 | $49.22 | 2,991 |
| $147K |
| 3.0% |
| 7 | $50.40 | 2,819 | $142K | 2.9% |
| 8 | $50.40 | 2,819 | $142K | 2.9% |
| 9 | $51.38 | 8,114 | $417K | 8.4% |
| 10 | $51.38 | 8,114 | $417K | 8.4% |
| 11 | $52.38 | 5,032 | $264K | 5.3% |
| 12 | $52.38 | 5,032 | $264K | 5.3% |
| 13 | $53.50 | 2,606 | $139K | 2.8% |
| 14 | $54.72 | 1,431 | $78K | 1.6% |
| 15 | $54.72 | 1,431 | $78K | 1.6% |
| 16 | $55.49 | 300 | $17K | 0.3% |
| Total | $49.23 avg | 101,124 | $5.0M | 100% |
| Filing → |
| VCYT | SELL | 2022-11-08 | $26K | — | Filing → |
| VCYT | SELL | 2022-08-09 | $27K | — | Filing → |
| VCYT | SELL | 2022-03-09 | $1.0M | — | Filing → |